PharmacoMicrobiology and PharmacoMicrobioResistance: Expanding the Paradigm of Drug-Microbe Interactions and Resistance Beyond Antimicrobials in the Pharmacosphere
Year: 2026
Type: preprint
Abstract: Antimicrobial resistance (AMR) is framed as a defining global health crisis, yet its conceptual boundaries remain artificially narrow. By focusing primarily on antibiotics, current paradigms ignore a broader reality: microorganisms continuously respond to the full spectrum of human and animal pharmaceuticals in both patients and the environment. This oversight obscures critical dimensions of drug action and resistance mechanisms. We propose PharmacoMicrobiology (PM) and PharmacoMicrobioResistance (PMR) to redefine microbial–drug interactions beyond traditional antimicrobials, specifically accounting for multiple simultaneous drug exposures. Microbes actively transform, degrade, and resist diverse non-antibiotic drugs, potentially undermining therapeutic efficacy across multiple distinct medical fields. Shaped by environmental contamination, microbiome dynamics, and horizontal gene transfer, resistance to these non-antibiotic drugs may already be emerging entirely unnoticed. Ignoring this expanded resistome risks repeating past failures. Integrating PM and PMR into comprehensive One Health frameworks, powered by advanced artificial intelligence, is essential to anticipate, detect, and prevent drug resistance.
Source: Preprints.org
Language: English
Subfield: Pollution
Field: Environmental Science
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W7234966606
